עקוב אחר
James M Stone
James M Stone
Brighton and Sussex Medical School; University of Sussex; University of Brighton
כתובת אימייל מאומתת בדומיין bsms.ac.uk
כותרת
צוטט על ידי
צוטט על ידי
שנה
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ...
Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012
12842012
Glutamate and dopamine in schizophrenia: An update for the 21st century
O Howes, R McCutcheon, J Stone
Journal of psychopharmacology 29 (2), 97-115, 2015
9232015
Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ...
Neuropsychopharmacology 35 (3), 764-774, 2010
8242010
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
A Englund, PD Morrison, J Nottage, D Hague, F Kane, S Bonaccorso, ...
Journal of psychopharmacology 27 (1), 19-27, 2013
5372013
Glutamate and dopamine dysregulation in schizophrenia—a synthesis and selective review
JM Stone, PD Morrison, LS Pilowsky
Journal of psychopharmacology 21 (4), 440-452, 2007
5312007
Complex I inhibitors induce dose‐dependent apoptosis in PC12 cells: relevance to Parkinson's disease
A Hartley, JM Stone, C Heron, JM Cooper, AHV Schapira
Journal of neurochemistry 63 (5), 1987-1990, 1994
4561994
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ...
Biological psychiatry 75 (5), e11-e13, 2014
3642014
Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis
VL Nikolova, MRB Smith, LJ Hall, AJ Cleare, JM Stone, AH Young
JAMA psychiatry 78 (12), 1343-1354, 2021
3482021
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ...
Molecular psychiatry 11 (2), 118-119, 2006
3432006
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
JM Stone, C Dietrich, R Edden, MA Mehta, S De Simoni, LJ Reed, ...
Molecular psychiatry 17 (7), 664-665, 2012
3082012
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study
A Mechelli, A Riecher-Rössler, EM Meisenzahl, S Tognin, SJ Wood, ...
Archives of general psychiatry 68 (5), 489-495, 2011
2852011
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume
JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ...
Biological psychiatry 66 (6), 533-539, 2009
2762009
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
RL Carhart-Harris, R Leech, D Erritzoe, TM Williams, JM Stone, J Evans, ...
Schizophrenia bulletin 39 (6), 1343-1351, 2013
2662013
The blood–brain barrier in psychosis
TA Pollak, S Drndarski, JM Stone, AS David, P McGuire, NJ Abbott
The Lancet Psychiatry 5 (1), 79-92, 2018
2502018
Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive
E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ...
Schizophrenia bulletin 42 (3), 744-752, 2016
2342016
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia
A Egerton, S Brugger, M Raffin, GJ Barker, DJ Lythgoe, PK McGuire, ...
Neuropsychopharmacology 37 (11), 2515-2521, 2012
2172012
Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology
TRE Barnes, R Drake, C Paton, SJ Cooper, B Deakin, IN Ferrier, ...
Journal of Psychopharmacology 34 (1), 3-78, 2020
2152020
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
P McGuire, OD Howes, J Stone, P Fusar-Poli
Trends in pharmacological sciences 29 (2), 91-98, 2008
1912008
Drug models of schizophrenia
H Steeds, RL Carhart-Harris, JM Stone
Therapeutic advances in psychopharmacology 5 (1), 43-58, 2015
1782015
Proton magnetic resonance spectroscopy and illness stage in schizophrenia—a systematic review and meta-analysis
S Brugger, JM Davis, S Leucht, JM Stone
Biological psychiatry 69 (5), 495-503, 2011
1772011
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20